PRLD (Prelude Therapeutics Incorporated) Stock Market Reviews

crown

search

Read and share opinions on PRLD (Prelude Therapeutics Incorporated) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the sto

PRLD

Prelude Therapeutics Incorporated

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Prelude Therapeutics Inc (PRLD) Q3 2025 Earnings Call Highlights: Strategic Partnerships and ...
Nov 12, 2025
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting
Nov 3, 2025
Prelude Therapeutics Announces Appointment of Katina Dorton, J.D., MBA to its Board of Directors
Oct 17, 2025
Can Prelude Therapeutics (NASDAQ:PRLD) Afford To Invest In Growth?
Aug 11, 2025
Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
Jun 2, 2025
Prelude Therapeutics to Participate in Citizens Life Sciences Conference
May 1, 2025
Prelude Announces Presentations at 2025 AACR Annual Meeting
Apr 25, 2025
Prelude Therapeutics (PRLD) Upgraded to Buy: Here's What You Should Know
Apr 10, 2025
Prelude Therapeutics Founder Acquires 28% More Stock
Mar 29, 2025

Reviews